Sasy Scientifics LLC

Sanaria Inc. is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Plasmodium falciparum malaria is responsible for more childhood mortality than any other single infectious agent. The firm s vaccine development efforts are focused on African children, the population most urgently in need of protection. Based in Rockville, Md., it houses a custom-designed and constructed dedicated clinical manufacturing facility for producing its attenuated malaria parasite vaccine. Sanaria Inc. has two ongoing Cooperative Research and Development Agreements (CRADAs) with U.S. government laboratories, a development contract with a biotechnology company, a funded research agreement with a nonprofit, and a services agreement with a nonprofit research institute and a government laboratory.

CosmosID, based in Germantown, MD, specializes in clinical microbiomics and has recently merged with DNASense and MS-Omics to form Cmbio, enhancing their metagenomic services. With over 12 years of experience, they offer a range of sequencing options including amplicon, shotgun, and bacterial isolate sequencing, supported by an industry-leading bioinformatics pipeline. The company is recognized for its exceptional customer service and has aided numerous organizations in scientific research and clinical diagnostics, helping to analyze microbial communities with high precision. CosmosID's robust data-driven solutions and user-friendly software facilitate comprehensive analyses, empowering clients across various sectors to effectively navigate the complexities of the microbiome. Generated from the website

OpGen, Inc., based in Rockville, MD, is a company that is expanding its horizons with the recent launch of its new fintech arm, CapForce. The organization is dedicated to innovation and advancement in various sectors, highlighting its commitment to growth and strategic development. With a structured management team and board of directors, OpGen emphasizes corporate governance and transparency for its investors. The company actively engages with shareholders and provides essential updates through news events and SEC filings. Generated from the website